Peer Review History

Original SubmissionFebruary 23, 2022
Decision Letter - Francois Blachier, Editor

PONE-D-22-05513Phylogenetic diversity analysis of shotgun metagenomic reads describes gut microbiome development and treatment effects in the post-weaned pigPLOS ONE

Dear Dr. Gaio,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during the review process. Notably, you will see that additional information are required, and that some minor modifications have been suggested.

Please submit your revised manuscript by Jun 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Francois Blachier, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following in the Competing Interests section: 

"I have read the journal's policy and the authors of this manuscript have the following competing interests: [D-Scour™ was sourced from International Animal Health Products (IAHP). ColiGuard® was developed in a research project with NSW DPI, IAHP and AusIndustry Commonwealth government funding.]"

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript (PONE-D-22-05513) entitled “Phylogenetic diversity analysis of shotgun metagenomic reads describes gut microbiome development and treatment effects in the post-weaned pig” analyzed the correlations between experimental factors and microbial community by phylogenetic diversity measures, which is rare at microbial community study. Overall, the manuscript has a large numbers of samples, high quality of writing, and the manuscript structure, data collection and data description were acceptable, I believe it is suitable for publication in the “PLOS ONE”. However, there are a few questions and mistakes need to be addressed before it can be formally accepted.

1.Line 102-104: The author mentioned that “All the 126 piglets consisted of 4 main cross-breed types”, but then they said “three pig lines (line 319: n=9; line 316: n=46; line 326: n=71)”, the description of “three pig lines” can not be understood. What is the “three pig lines”?

2.Line 110-113: The 6 treatment cohorts were described at these line, and the number of piglets were 125, however the author mentioned that “Post-weaning piglets (n=126)”, Why is the number of piglets inconsistent?

3.What is the breeds composition of each treatment? How to eliminate breed effects when analyzing data?

4.Line 132-133: “18 samples derived from three distinct positive controls (D-Scour™, ColiGuard®, and mock community), and 20 negative controls were included.” The information of positive controls and negative controls is unclear in this manuscript, it should be more clearly described in the manuscript.

5.According to Figure 1, we can see that placebo paste was used as Control, and the antibiotic group only used Neomycin for 4 days, why not used Neomycin+ placebo paste to compare with Neomycin+D-Scour and Neomycin+ColiGuard?

6.There are 13 tables in S1 Table, so it is hard to find the data when the manuscript says “ (Supplementary Table 1).”

7.The manuscript mentioned that: “Euthanasia is described in our previous work (54)”, but I did not find any information about euthanasia through the manuscript “A large-scale metagenomic survey dataset of the post-weaning piglet gut lumen.” And what samples were collected after euthanasia?

8.Some explanatory text overlap with the graph, such as “Supplementary Figure 8”, which should be noticed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

(please see uploaded file, as there are figures as well for the reviewer to view, that cannot be pasted in the text box here)

Reviewer #1: The manuscript (PONE-D-22-05513) entitled “Phylogenetic diversity analysis of shotgun metagenomic reads describes gut microbiome development and treatment effects in the post-weaned pig” analyzed the correlations between experimental factors and microbial community by phylogenetic diversity measures, which is rare at microbial community study. Overall, the manuscript has a large numbers of samples, high quality of writing, and the manuscript structure, data collection and data description were acceptable, I believe it is suitable for publication in the “PLOS ONE”. However, there are a few questions and mistakes need to be addressed before it can be formally accepted.

1.Line 102-104: The author mentioned that “All the 126 piglets consisted of 4 main cross-breed types”, but then they said “three pig lines (line 319: n=9; line 316: n=46; line 326: n=71)”, the description of “three pig lines” can not be understood. What is the “three pig lines”?

Yes, “pig lines” reflect the cross-breeds of the piglets, as follows:

Line 316: Duroc sire x Landrace dam

Line 319: Landrace sire x cross bred (Large White x Duroc) dam

Line 326: Duroc sire x Large White dam, as well as viceversa (Large White sire x Duroc dam)

The term “line”used here is possibly misleading given that the term line breeding (in animal breeding) usually refers to either a sire line in common or, less commonly, a dam line in common.

Additionally, piglets derived from a Duroc sire x LW dam cross are different from piglets derived from a LW sire x Duroc dam, and this distinction is not to be appreciated if both are described with the same “pig line”. The host factor “cross-breed”, on the contrary, includes this distinction.

For these reasons we decided to avoid bringing up the term “pig lines”, and we eliminated the analysis of lines as a host factor. Hence Supplementary Table 1 and Figure 2 have been modified accordingly. The manuscript has also been revised to reflect these changes. Without the input from Reviewer 1, we would have overlooked this detail. Thank you.

2.Line 110-113: The 6 treatment cohorts were described at these line, and the number of piglets were 125, however the author mentioned that “Post-weaning piglets (n=126)”, Why is the number of piglets inconsistent?

Yes, it is true. One piglet developed swine dysentery 2 weeks into the trial and was therefore excluded. This information was in fact missing and we now adapted the revised manuscript to report this.

3.What is the breeds composition of each treatment? How to eliminate breed effects when analyzing data?

While technical batch effects can be removed OR accounted for (as we did for the DNA extraction plate batch effect), biological batch effects (such as breed and age), could only be accounted for. Treating biological, non-systematic batch effects as systematic, might result in the removal of the biological signal, while the batch variation may remain. (Yiwen Wang, Kim-Anh LêCao, Managing batch effects in microbiome data, Briefings in Bioinformatics, Volume 21, Issue 6, November 2020, Pages 1954–1970, https://doi.org/10.1093/bib/bbz105; Yiwen Wang, Kim-Anh LêCao, A multivariate method to correct for batch effects in microbiome data, bioRxiv 2020.10.27.358283; doi: https://doi.org/10.1101/2020.10.27.358283).

The most sensible way to go about biological batch effects is to balance host (breed and age) factors across the experimental (treatment) groups. We strived to achieve this by randomly allocating the piglets across the rooms. This resulted in a roughly equal distribution of breeds (and ages) across the 6 treatment cohorts as it can be seen in the plot below: (please see pdf file "rebuttal letter)

*Abbreviations: LW x D = Large White x Duroc

4.Line 132-133: “18 samples derived from three distinct positive controls (D-Scour™, ColiGuard®, and mock community), and 20 negative controls were included.” The information of positive controls and negative controls is unclear in this manuscript, it should be more clearly described in the manuscript.

We agree it was not clear as it was split over two paragraphs. We adapted the text in the revised manuscript and we added a description of the negative controls, which was missing.

5.According to Figure 1, we can see that placebo paste was used as Control, and the antibiotic group only used Neomycin for 4 days, why not used Neomycin+ placebo paste to compare with Neomycin+D-Scour and Neomycin+ColiGuard?

The reason for not treating the neomycin group with the placebo paste was that the study was designed to match treatments that would be used in the real world (i.e. in a commercial piggery). So neomycin alone would be one such treatment, according to current pig veterinary practice Dr H. Dunlop pers.comm.), as would be the sequential treatment of two actives neomycin and D-Scour.

6.There are 13 tables in S1 Table, so it is hard to find the data when the manuscript says “ (Supplementary Table 1).”

Yes, we agree. The disadvantage of having 13 separate tables is that the reader would have to open 13 distinct files to find the statistical reports. However we agree with the reviewer’s comment that it might be hard to understand which of the 13 tables a particular sentence refers to. To solve this, we added the name of the sheets the “Supplementary Table 1” refers to in the revised manuscript.

7.The manuscript mentioned that: “Euthanasia is described in our previous work (54)”, but I did not find any information about euthanasia through the manuscript “A large-scale metagenomic survey dataset of the post-weaning piglet gut lumen.” And what samples were collected after euthanasia?

Yes, we made a mistake by citing the wrong publication. We did describe euthanasia in the bioRxiv version https://doi.org/10.1101/2020.07.20.211326 as follows:

“Groups of piglets were euthanized at the start (t0: n=6), a week after (t2: n=12), two weeks after the start of the trial (t4: n=36) and at the end of the trial (t10: n=72) to obtain biopsy samples that were used in another study. All surviving animals were euthanized at the end of the animal trial. Euthanasia occurred as follows: the piglets were restrained in dorsal recumbency in a bleeding cradle and pentobartitone euthanasia solution (Lethabarb, Virbac Australia, 325 mg pentobarbitone sodium/mL) diluted 1:1 in sterile normal saline was administered via the precava using a 20-21G needle depending on pig weight. The piglets received a dose of approximately 30 mg pentobarbitone/Kg to achieve deep anaesthesia, and then immediately exsanguinated. Exsanguination after a non-lethal dose of barbiturate was undertaken to reduce excessive congestion of the visceral blood vessels at the time of intestinal specimen collection (which is likely to occur if euthanasia is undertaken using an overdose of barbiturate alone). “

We revised the manuscript by citing the correct article where euthanasia is described, and by shortly describing the type of biopsy samples we collected.

8.Some explanatory text overlap with the graph, such as “Supplementary Figure 8”, which should be noticed.

Yes, there were in fact overlaps with the statistical reports (anova) and the time interval reports. Supplementary Figure 8 has been replaced in the revised manuscript.

Attachments
Attachment
Submitted filename: Response_to_reviewers_20220605.pdf
Decision Letter - Francois Blachier, Editor

Phylogenetic diversity analysis of shotgun metagenomic reads describes gut microbiome development and treatment effects in the post-weaned pig

PONE-D-22-05513R1

Dear Dr. Gaio,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Francois Blachier, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Francois Blachier, Editor

PONE-D-22-05513R1

Phylogenetic diversity analysis of shotgun metagenomic reads describes gut microbiome development and treatment effects in the post-weaned pig

Dear Dr. Gaio:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Francois Blachier

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .